Fontem LLC, the parent to Blu products, is expected to appeal the regulatory agency's decision.Read More
Tags :Fontem
The denied Blu PLUS+ products include a battery and several prefilled tobacco flavored e-liquid pods.Read More
This is the second circuit court of appeals to accuse the FDA of a "surprise switcheroo" when reviewing PMTAs.Read More
The company may resubmit a new marketing application to address the deficiencies for the product.Read More
As recently as May 2019, Juul held a 74.6 percent U.S. e-cig market share that is now below 27 percent.Read More
The court denied the stay mainly because Fontem waited too long to file the emergency motion.Read More
FDA states that it expects to have resolved 63 percent of PMTAs set out in its original priority by June 30.Read More
Fontem Ventures, a subsidiary of Imperial Brands PLC, owns the global e-cigarette brand blu. Read More
Sales in C-stores are up 12.7 percent after rising 2.9 percent in the previous data release.Read More
Imperial Brands subsidiary Fontem US has submitted PMTAs to the U.S. FDA for next-generation products.Read More
